In a meta-analysis involving 40 studies and 95,617 participants without history of CVD, NT-proBNP strongly predicted first-onset manifestation of HF while providing risk prediction for stroke and coronary artery disease [7]. This evidence concerns the gene NPPB and stroke disorder.